Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach (CaRVD)

NCT05215171 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT05215171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05215171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach (CaRVD)
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Recruiting
Start date
March 30, 2023
Completion date
June 30, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiorespiratory and vascular dysfunction, obstructive airway disease